Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression
Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial...
Gespeichert in:
| Veröffentlicht in: | The international journal of neuropsychopharmacology Jg. 17; H. 10; S. 1569 - 1578 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Cambridge, UK
Cambridge University Press
01.10.2014
Oxford University Press |
| Schlagworte: | |
| ISSN: | 1461-1457, 1469-5111, 1469-5111 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C, and the metabotropic receptor genes, GRM4 and GRM5, in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects. |
|---|---|
| AbstractList | Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C, and the metabotropic receptor genes, GRM4 and GRM5, in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects. Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C , and the metabotropic receptor genes, GRM4 and GRM5 , in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects. Abstract Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C, and the metabotropic receptor genes, GRM4 and GRM5, in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects. [PUBLICATION ABSTRACT] Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C, and the metabotropic receptor genes, GRM4 and GRM5, in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects.Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to suicide completion. Antagonists of glutamatergic NMDA receptors reduce depressive symptoms faster than traditional antidepressants, with beneficial effects occurring within hours. Glutamate is the prominent excitatory input to the noradrenergic locus coeruleus (LC). The LC is activated by stress in part through this glutamatergic input. Evidence has accrued demonstrating that the LC may be overactive in MDD, while treatment with traditional antidepressants reduces LC activity. Pathological alterations of both glutamatergic and noradrenergic systems have been observed in depressive disorders, raising the prospect that disrupted glutamate-norepinephrine interactions may be a central component to depression and suicide pathobiology. This study examined the gene expression levels of glutamate receptors in post-mortem noradrenergic LC neurons from subjects with MDD (most died by suicide) and matched psychiatrically normal controls. Gene expression levels of glutamate receptors or receptor subunits were measured in LC neurons collected by laser capture microdissection. MDD subjects exhibited significantly higher expression levels of the NMDA receptor subunit genes, GRIN2B and GRIN2C, and the metabotropic receptor genes, GRM4 and GRM5, in LC neurons. Gene expression levels of these receptors in pyramidal neurons from prefrontal cortex (BA10) did not reveal abnormalities in MDD. These findings implicate disrupted glutamatergic-noradrenergic interactions at the level of the stress-sensitive LC in MDD and suicide, and provide a theoretical mechanism by which glutamate antagonists may exert rapid antidepressant effects. |
| Author | Chandley, Michelle J. Kostrzewa, Richard M. Crawford, Jessica D. Stockmeier, Craig A. Ordway, Gregory A. Turecki, Gustavo Szebeni, Attila Szebeni, Katalin |
| Author_xml | – sequence: 1 givenname: Michelle J. surname: Chandley fullname: Chandley, Michelle J. organization: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA – sequence: 2 givenname: Attila surname: Szebeni fullname: Szebeni, Attila organization: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA – sequence: 3 givenname: Katalin surname: Szebeni fullname: Szebeni, Katalin organization: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA – sequence: 4 givenname: Jessica D. surname: Crawford fullname: Crawford, Jessica D. organization: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA – sequence: 5 givenname: Craig A. surname: Stockmeier fullname: Stockmeier, Craig A. organization: Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS, USA – sequence: 6 givenname: Gustavo surname: Turecki fullname: Turecki, Gustavo organization: Department of Psychiatry, McGill University, Montreal, PQ, Canada – sequence: 7 givenname: Richard M. surname: Kostrzewa fullname: Kostrzewa, Richard M. organization: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA – sequence: 8 givenname: Gregory A. surname: Ordway fullname: Ordway, Gregory A. email: ordway@etsu.edu organization: Department of Biomedical Sciences, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24925192$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtv1TAQhS1URB_wA9ggS2xYEPDYjuMsUVUeUiUWwDpynMklV4kd_EDw73F6bxEqomJly_OdM-Mz5-TEeYeEPAX2Chg0rz-BVACybkAyxpTiD8hZeWqrGgBObu5QbfVTch7jnjEua6EekVMuW15Dy89Ivprxu0k40B06pPhjDRjj5B31I93NOZmlVGlAi2vyIdLJUeeDGULBw26y1GEO3kU6Br_Q9BXp7G2O1HoMecZ8o1jM3gc64K35Y_JwNHPEJ8fzgnx5e_X58n11_fHdh8s315VVuklVL3htLbRNLzTUOAiurURhwfLG6MaIUVoUglnUYz-Y0WprtELRG2l7BlJckBcH3zX4bxlj6pYpWpxn49Dn2EGttry4bgv6_A669zm4Ml0nQLValbjkfdTmxViZeKOeHancLzh0a5gWE352t7EXAA6ADT7GgONvBFi3rbb7a7VF09zR2CmZVNJMwUzzvcqXB6XP6381EsdGZunDNOzwj0_-U_ULrd_DcA |
| CitedBy_id | crossref_primary_10_1016_j_jad_2023_07_003 crossref_primary_10_1111_cns_13999 crossref_primary_10_1038_nrd_2017_16 crossref_primary_10_1038_mp_2017_141 crossref_primary_10_1186_s13041_021_00817_3 crossref_primary_10_1007_s11064_020_03212_x crossref_primary_10_1155_2022_6334868 crossref_primary_10_5498_wjp_v12_i7_884 crossref_primary_10_1016_j_neuropharm_2022_109351 crossref_primary_10_1016_j_aca_2019_02_054 crossref_primary_10_3390_brainsci12050651 crossref_primary_10_1111_ajad_12571 crossref_primary_10_1038_s41398_021_01469_6 crossref_primary_10_1097_MS9_0000000000002487 crossref_primary_10_1007_s40142_017_0112_y crossref_primary_10_3389_fimmu_2021_707267 crossref_primary_10_3390_biom10060947 crossref_primary_10_3390_genes15050565 crossref_primary_10_1016_j_pnpbp_2020_110041 crossref_primary_10_3390_ijms231911423 crossref_primary_10_3390_brainsci9080183 crossref_primary_10_3389_fncel_2022_869779 crossref_primary_10_1016_j_neubiorev_2017_08_023 crossref_primary_10_1016_j_prmcm_2023_100284 crossref_primary_10_3389_fgene_2018_00257 crossref_primary_10_1007_s11011_022_01081_7 crossref_primary_10_1016_j_pharmthera_2021_107875 crossref_primary_10_1523_JNEUROSCI_1164_19_2019 crossref_primary_10_1016_j_phymed_2025_156927 crossref_primary_10_1007_s00018_015_2044_6 crossref_primary_10_3390_brainsci14010050 crossref_primary_10_1016_j_job_2025_100628 crossref_primary_10_1097_YIC_0000000000000455 crossref_primary_10_1016_j_neubiorev_2024_105925 crossref_primary_10_1016_j_euroneuro_2020_08_007 crossref_primary_10_1186_s13148_015_0071_7 crossref_primary_10_1016_j_jpsychires_2024_11_044 crossref_primary_10_1007_s00210_022_02229_z crossref_primary_10_1111_ejn_15495 crossref_primary_10_3390_ijms21217951 crossref_primary_10_1038_s41380_023_02235_4 crossref_primary_10_2217_epi_2020_0196 crossref_primary_10_1002_ps_5978 crossref_primary_10_1080_13880209_2019_1598445 crossref_primary_10_1186_s13063_015_0609_1 crossref_primary_10_1016_j_pnpbp_2025_111390 crossref_primary_10_1016_j_bpsc_2024_11_014 crossref_primary_10_3390_brainsci12101329 crossref_primary_10_1038_tp_2015_154 crossref_primary_10_1016_j_psychres_2015_10_032 crossref_primary_10_1016_j_jad_2023_01_031 crossref_primary_10_1016_j_pnpbp_2017_10_002 crossref_primary_10_1038_tpj_2015_15 crossref_primary_10_1038_s41572_019_0121_0 crossref_primary_10_1159_000527182 crossref_primary_10_1113_JP283605 crossref_primary_10_1093_ijnp_pyae022 crossref_primary_10_3390_biology9110359 crossref_primary_10_1016_j_ymeth_2022_08_013 crossref_primary_10_1038_s41398_019_0635_y crossref_primary_10_1016_j_jpsychires_2023_02_017 crossref_primary_10_1016_j_neulet_2015_08_038 crossref_primary_10_1016_j_neulet_2021_135980 crossref_primary_10_1017_neu_2024_39 crossref_primary_10_1007_s12264_021_00638_3 crossref_primary_10_1016_j_genhosppsych_2021_04_006 crossref_primary_10_1134_S2079059715060027 crossref_primary_10_1038_s41398_021_01285_y crossref_primary_10_4103_1673_5374_235019 crossref_primary_10_1073_pnas_1818871116 crossref_primary_10_1002_mco2_156 crossref_primary_10_1038_s41598_017_04300_9 |
| Cites_doi | 10.1016/S0896-6273(02)00828-0 10.1016/S0006-3223(00)00936-7 10.1001/archpsyc.61.7.705 10.1016/j.biopsych.2009.04.029 10.1001/archpsyc.56.5.395 10.1111/j.1471-4159.1992.tb09748.x 10.1016/0304-3940(95)12102-A 10.1016/S0006-8993(97)00703-8 10.1017/S1461145708009474 10.1038/sj.npp.1300781 10.1038/nature05453 10.1016/j.mehy.2011.06.021 10.1093/nar/gkn141 10.1002/cne.901870103 10.1126/science.3775363 10.1073/pnas.88.19.8382 10.1523/JNEUROSCI.5019-04.2005 10.1046/j.1365-2826.2002.00821.x 10.1523/JNEUROSCI.17-22-08842.1997 10.1503/jpn.120110 10.1007/BF02245873 10.1007/s00213-005-2142-5 10.1016/j.neuropharm.2012.04.007 10.1521/suli.2009.39.1.38 10.1111/j.1476-5381.2008.00004.x 10.1001/archpsyc.65.5.521 10.1007/BF00964456 10.1002/jnr.22078 10.1016/j.mehy.2007.03.021 10.1016/j.eurpsy.2010.01.009 10.1001/jama.2011.1080 10.1016/0006-8993(91)90939-S 10.1111/j.1600-0447.1996.tb09869.x 10.1001/archpsyc.1986.01800060071009 10.1016/j.brainres.2007.08.007 10.1001/archpsyc.63.8.856 10.4088/JCP.v69n0308 10.1146/annurev.pharmtox.37.1.205 10.1016/j.jad.2010.06.003 10.1006/geno.2002.6748 10.4088/JCP.09m05327blu |
| ContentType | Journal Article |
| Copyright | CINP 2014 CINP 2014 2014 CINP 2014. |
| Copyright_xml | – notice: CINP 2014 – notice: CINP 2014 2014 – notice: CINP 2014. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 88G 8AO 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ K9. M0S M1P M2M PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
| DOI | 10.1017/S1461145714000662 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | M.J. Chandley et al. Elevated glutamate receptor gene expression in MDD |
| EISSN | 1469-5111 |
| EndPage | 1578 |
| ExternalDocumentID | 3427251121 24925192 10_1017_S1461145714000662 10.1017/S1461145714000662 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NCRR NIH HHS grantid: RR17701 – fundername: NIGMS NIH HHS grantid: GM103328 – fundername: NIMH NIH HHS grantid: MH46692 |
| GroupedDBID | --- -E. .FH 0E1 0R~ 0VX 123 29J 3V. 4.4 53G 5VS 74X 74Y 7X7 7~V 88E 8AO 8FI 8FJ 8R4 8R5 AAFWJ AAMVS AAOGV AAPPN AAPXW AAVAP ABITZ ABIVO ABKKG ABMYL ABPTD ABQLI ABUWG ABXVV ACGFS ACIMK ADBBV ADHZD ADRAZ AEMTW AENEX AENZO AFFVI AFKRA AFPKN AFULF AFUTZ AHMBA AJ7 ALMA_UNASSIGNED_HOLDINGS ALUQC AOIJS ARABE AVWKF AZQEC BAWUL BAYMD BCNDV BENPR BPHCQ BTTYL BVXVI C0O CAG CCPQU CIDKT COF CS3 DC4 DIK DU5 DWQXO EBS EJD EMOBN FYUFA GNUQQ GROUPED_DOAJ HG- HMCUK HST HYE HZ~ I.6 IAO IHR I~P J36 J38 J3A KQ8 KSI L98 LW7 M-V M1P M2M M48 ML0 M~E O9- OAWHX OJQWA OJZSN OK1 P2P PEELM PQQKQ PROAC PSQYO PSYQQ Q2X RHF RIG ROL ROX RPM RR0 S6- S70 TJX TOX TUQ UKHRP UU6 WQ3 WXU WXY WYP ABEJV ABGNP ABVKB ALIPV AMNDL H13 PIMPY AAYXX AFFHD CITATION ITC PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 |
| ID | FETCH-LOGICAL-c687t-b325cc197b3815ed328c4e3c1c27a87a3f4ce330ce8fbdafc8ca86e3ba4cb0143 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 82 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000345004900005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1461-1457 1469-5111 |
| IngestDate | Sun Nov 09 12:34:02 EST 2025 Tue Oct 07 05:17:36 EDT 2025 Mon Oct 06 18:33:43 EDT 2025 Thu Apr 03 07:05:01 EDT 2025 Sat Nov 29 06:00:43 EST 2025 Tue Nov 18 22:33:04 EST 2025 Tue Feb 04 08:58:37 EST 2025 Wed Mar 13 05:54:33 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | Glutamate receptors locus coeruleus neurons major depression suicide |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c687t-b325cc197b3815ed328c4e3c1c27a87a3f4ce330ce8fbdafc8ca86e3ba4cb0143 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/3169861924?pq-origsite=%requestingapplication% |
| PMID | 24925192 |
| PQID | 1561003254 |
| PQPubID | 43629 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_1561469289 proquest_journals_3169861924 proquest_journals_1561003254 pubmed_primary_24925192 crossref_primary_10_1017_S1461145714000662 crossref_citationtrail_10_1017_S1461145714000662 oup_primary_10_1017_S1461145714000662 cambridge_journals_10_1017_S1461145714000662 |
| PublicationCentury | 2000 |
| PublicationDate | 2014-10-01 |
| PublicationDateYYYYMMDD | 2014-10-01 |
| PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Cambridge, UK |
| PublicationPlace_xml | – name: Cambridge, UK – name: England – name: Oxford |
| PublicationTitle | The international journal of neuropsychopharmacology |
| PublicationTitleAlternate | Int. J. Neuropsychopharm |
| PublicationYear | 2014 |
| Publisher | Cambridge University Press Oxford University Press |
| Publisher_xml | – name: Cambridge University Press – name: Oxford University Press |
| References | Conn, Pin 1997; 37 Muhonen, Lönnqvist, Juva, Alho 2008; 69 Weiss, Bailey, Pohorecky, Korzeniowski, Grillione 1980; 5 Mann, Currier 2010; 25 Marsden 2011; 77 Olpe, Steinmann, Brugger, Pozza 1989; 339 Lein 2007; 445 Dhir, Kulkarni 2008; 21 Diazgranados, Ibrahim, Brutsche, Ameli, Henter, Luckenbaugh, Machado-Vieira, Zarate 2010; 71 Sartorius, Henn 2007; 69 Karolewicz, Stockmeier, Ordway 2005; 30 2008; 36 Murase, Nisell, Grenhoff, Svensson 1992; 109 Page, Szeliga, Gasparini, Cryan 2005; 179 Herkenham, Nauta 1979; 187 Grant, Weiss 2001; 49 Dejong, Overholser 2009; 39 Berman, Narasimhan, Miller, Anand, Cappiello, Oren, Heninger, Charney 1999; 56 Hughes 2013; 66 Price, Nock, Charney, Mathew 2009; 66 Aston-Jones, Ennis, Pieribone, Nickell, Shipley 1986; 234 Heinsbroek, Van Haaren, Feenstra, Boon, Van de Poll 1991; 551 Melia, Rasmussen, Terwilliger, Haycock, Nestler, Duman 1992; 58 Harrison, Heath, Eastwood, Burnet, McDonald, Pearson 1995; 200 Ordway, Szebeni, Duffourc, Dessus-Babus, Szebeni 2009; 87 Zamalloa, Bailey, Pineda 2009; 156 Curtis, Bello, Connolly, Valentino 2002; 14 Noriega, Garyfallou, Kohama, Urbanski 2007; 1173 Melia, Duman 1991; 88 Kollack-Walker, Watson, Akil 1997; 17 Zarate, Singh, Carlson, Brutsche, Ameli, Luckenbaugh, Charney, Manji 2006; 63 Papadia, Stevenson, Hardingham, Bading, Hardingham 2005; 25 West, Ritchie, Boss-Williams, Weiss 2009; 12 Jodo, Aston-Jones 1997; 768 Sanacora, Gueorguieva, Epperson, Wu, Appel, Rothman, Krystal, Mason 2004; 61 Krystal, Rosenheck, Cramer, Vessicchio, Jones, Vertrees, Horney, Huang, Stock 2011; 306 Wain, Bruford, Lovering, Lush, Wright, Povey 2002; 79 Rich, Young, Fowler 1986; 43 Kelly, Mann 1996; 94 Lonze, Ginty 2002; 35 Miguel-Hidalgo, Waltzer, Whittom, Austin, Rajkowska, Stockmeier 2010; 127 Beskow 1979; 277 Chandley, Szebeni, Szebeni, Crawford, Stockmeier, Turecki, Miguel-Hidalgo, Ordway 2013; 38 Hasler, Fromm, Carlson, Luckenbaugh, Waldeck, Geraci, Roiser, Neumeister, Meyers, Charney, Drevets 2008; 65 S1461145714000662_ref32 S1461145714000662_ref10 S1461145714000662_ref33 S1461145714000662_ref11 S1461145714000662_ref30 S1461145714000662_ref36 S1461145714000662_ref14 S1461145714000662_ref37 S1461145714000662_ref15 S1461145714000662_ref34 (S1461145714000662_ref19) 1997; 17 S1461145714000662_ref12 S1461145714000662_ref35 S1461145714000662_ref13 S1461145714000662_ref18 S1461145714000662_ref16 S1461145714000662_ref38 S1461145714000662_ref39 S1461145714000662_ref17 S1461145714000662_ref9 S1461145714000662_ref7 S1461145714000662_ref5 S1461145714000662_ref40 S1461145714000662_ref6 S1461145714000662_ref4 S1461145714000662_ref1 S1461145714000662_ref21 S1461145714000662_ref43 S1461145714000662_ref2 S1461145714000662_ref22 S1461145714000662_ref44 S1461145714000662_ref41 S1461145714000662_ref20 S1461145714000662_ref42 S1461145714000662_ref25 S1461145714000662_ref26 S1461145714000662_ref24 S1461145714000662_ref29 S1461145714000662_ref27 S1461145714000662_ref28 (S1461145714000662_ref31) 1989; 339 (S1461145714000662_ref8) 2008; 21 (S1461145714000662_ref3) 1979; 277 (S1461145714000662_ref23) 2010; 25 |
| References_xml | – volume: 14 start-page: 667 year: 2002 end-page: 682 article-title: Corticotropin-releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress publication-title: J Neuroendocrinol – volume: 36 start-page: D190 year: 2008 end-page: D195 article-title: The universal protein resource (UniProt) publication-title: Nucleic Acids Res – volume: 306 start-page: 493 year: 2011 end-page: 502 article-title: Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial publication-title: JAMA – volume: 109 start-page: 271 year: 1992 end-page: 276 article-title: Decreased sensory responsiveness of noradrenergic neurons in the rat locus coeruleus following phencyclidine or dizocilpine (MK-801): role of NMDA antagonism publication-title: Psychopharmacol – volume: 58 start-page: 494 year: 1992 end-page: 502 article-title: Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments publication-title: J Neurochem – volume: 179 start-page: 240 year: 2005 end-page: 246 article-title: Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodents publication-title: Psychopharmacol – volume: 66 start-page: 202 year: 2013 end-page: 214 article-title: Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression publication-title: Neuropharmacol – volume: 445 start-page: 168 year: 2007 end-page: 176 article-title: Genome-wide atlas of gene expression in the adult mouse brain publication-title: Nature – volume: 35 start-page: 605 year: 2002 end-page: 623 article-title: Function and regulation of CREB family transcription factors in the nervous system publication-title: Neuron – volume: 63 start-page: 856 year: 2006 end-page: 864 article-title: A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression publication-title: Arch Gen Psychiatry – volume: 200 start-page: 151 year: 1995 end-page: 154 article-title: The relative importance of premortem acidosis and post-mortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins publication-title: Neurosci Lett – volume: 49 start-page: 117 year: 2001 end-page: 129 article-title: Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity publication-title: Biol Psychiatry – volume: 87 start-page: 2430 year: 2009 end-page: 2438 article-title: Gene expression analyses of neurons, astrocytes, and oligodendrocytes isolated by laser capture microdissection from human brain: detrimental effects of laboratory humidity publication-title: J Neurosci Res – volume: 21 start-page: 581 year: 2008 end-page: 592 article-title: New therapeutic promises in the treatment of depression and schizophrenia publication-title: Drug News Perspect – volume: 65 start-page: 521 year: 2008 end-page: 531 article-title: Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects publication-title: Arch Gen Psychiatry – volume: 66 start-page: 522 year: 2009 end-page: 526 article-title: Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression publication-title: Biol Psychiatry – volume: 37 start-page: 205 year: 1997 end-page: 237 article-title: Pharmacology and functions of metabotropic glutamate receptors publication-title: Annu Rev Pharmacol Toxicol – volume: 25 start-page: 4279 year: 2005 end-page: 4287 article-title: Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection publication-title: J Neurosci – volume: 61 start-page: 705 year: 2004 end-page: 713 article-title: Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression publication-title: Arch Gen Psychiatry – volume: 69 start-page: 1305 year: 2007 end-page: 1308 article-title: Deep brain stimulation of the lateral habenula in treatment resistant major depression publication-title: Med Hypotheses – volume: 234 start-page: 734 year: 1986 end-page: 737 article-title: The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network publication-title: Science (New York, NY) – volume: 38 start-page: 276 year: 2013 end-page: 284 article-title: Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder publication-title: J Psychiatry Neurosci: JPN – volume: 88 start-page: 8382 year: 1991 end-page: 8386 article-title: Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system publication-title: Proc Natl Acad Sci USA – volume: 69 start-page: 392 year: 2008 end-page: 399 article-title: Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence publication-title: J Clin Psychiatry – volume: 127 start-page: 230 year: 2010 end-page: 240 article-title: Glial and glutamatergic markers in depression, alcoholism, and their comorbidity publication-title: J Affect Disord – volume: 39 start-page: 38 year: 2009 end-page: 46 article-title: Assessment of depression and suicidal actions: agreement between suicide attempters and informant reports publication-title: Suicide Life Threat Behav – volume: 94 start-page: 337 year: 1996 end-page: 343 article-title: Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis publication-title: Acta Psychiatr Scand – volume: 17 start-page: 8842 year: 1997 end-page: 8855 article-title: Social stress in hamsters: defeat activates specific neurocircuits within the brain publication-title: J Neurosci – volume: 277 start-page: 1 year: 1979 end-page: 138 article-title: Suicide in mental disorder in Swedish men publication-title: Acta Psychiatr Scand – volume: 551 start-page: 247 year: 1991 end-page: 255 article-title: Controllable and uncontrollable footshock and monoaminergic activity in the frontal cortex of male and female rats publication-title: Brain Res – volume: 71 start-page: 1605 year: 2010 end-page: 1611 article-title: Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder publication-title: J Clin Psychiatry – volume: 12 start-page: 627 year: 2009 end-page: 641 article-title: Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons publication-title: Int J Neuropsychopharmacol – volume: 156 start-page: 649 year: 2009 end-page: 661 article-title: Glutamate-induced post-activation inhibition of locus coeruleus neurons is mediated by AMPA/kainate receptors and sodium-dependent potassium currents publication-title: Br J Pharmacol – volume: 5 start-page: 9 year: 1980 end-page: 22 article-title: Stress-induced depression of motor activity correlates with regional changes in brain norepinephrine but not in dopamine publication-title: Neurochem Res – volume: 30 start-page: 1557 year: 2005 end-page: 1567 article-title: Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression publication-title: Neuropsychopharmacol – volume: 768 start-page: 327 year: 1997 end-page: 332 article-title: Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs publication-title: Brain Res – volume: 77 start-page: 508 year: 2011 end-page: 528 article-title: Stressor-induced NMDAR dysfunction as a unifying hypothesis for the aetiology, pathogenesis and comorbidity of clinical depression publication-title: Med Hypotheses – volume: 339 start-page: 312 year: 1989 end-page: 314 article-title: Excitatory amino acid receptors in rat locus coeruleus. An extracellular in vitro study publication-title: Naunyn Schmiedebergs Arch Pharmacol – volume: 187 start-page: 19 year: 1979 end-page: 47 article-title: Efferent connections of the habenular nuclei in the rat publication-title: J Comp Neurol – volume: 43 start-page: 577 year: 1986 end-page: 582 article-title: San Diego suicide study. I. Young vs old subjects publication-title: Arch Gen Psychiatry – volume: 25 start-page: 268 year: 2010 end-page: 271 article-title: Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression publication-title: Eur Psychiatry – volume: 1173 start-page: 53 year: 2007 end-page: 65 article-title: Glutamate receptor subunit expression in the rhesus macaque locus coeruleus publication-title: Brain Res – volume: 79 start-page: 464 year: 2002 end-page: 470 article-title: Guidelines for human gene nomenclature publication-title: Genomics – volume: 56 start-page: 395 year: 1999 end-page: 403 article-title: Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? publication-title: Arch Gen Psychiatry – ident: S1461145714000662_ref22 doi: 10.1016/S0896-6273(02)00828-0 – ident: S1461145714000662_ref10 doi: 10.1016/S0006-3223(00)00936-7 – ident: S1461145714000662_ref37 doi: 10.1001/archpsyc.61.7.705 – ident: S1461145714000662_ref35 doi: 10.1016/j.biopsych.2009.04.029 – ident: S1461145714000662_ref2 doi: 10.1001/archpsyc.56.5.395 – ident: S1461145714000662_ref26 doi: 10.1111/j.1471-4159.1992.tb09748.x – ident: S1461145714000662_ref11 doi: 10.1016/0304-3940(95)12102-A – ident: S1461145714000662_ref16 doi: 10.1016/S0006-8993(97)00703-8 – ident: S1461145714000662_ref42 doi: 10.1017/S1461145708009474 – ident: S1461145714000662_ref17 doi: 10.1038/sj.npp.1300781 – ident: S1461145714000662_ref21 doi: 10.1038/nature05453 – ident: S1461145714000662_ref24 doi: 10.1016/j.mehy.2011.06.021 – ident: S1461145714000662_ref39 doi: 10.1093/nar/gkn141 – volume: 21 start-page: 581 year: 2008 ident: S1461145714000662_ref8 publication-title: Drug News Perspect – ident: S1461145714000662_ref14 doi: 10.1002/cne.901870103 – ident: S1461145714000662_ref1 doi: 10.1126/science.3775363 – ident: S1461145714000662_ref25 doi: 10.1073/pnas.88.19.8382 – ident: S1461145714000662_ref34 doi: 10.1523/JNEUROSCI.5019-04.2005 – ident: S1461145714000662_ref6 doi: 10.1046/j.1365-2826.2002.00821.x – volume: 17 start-page: 8842 year: 1997 ident: S1461145714000662_ref19 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.17-22-08842.1997 – ident: S1461145714000662_ref4 doi: 10.1503/jpn.120110 – volume: 339 start-page: 312 year: 1989 ident: S1461145714000662_ref31 publication-title: Naunyn Schmiedebergs Arch Pharmacol – ident: S1461145714000662_ref29 doi: 10.1007/BF02245873 – ident: S1461145714000662_ref33 doi: 10.1007/s00213-005-2142-5 – ident: S1461145714000662_ref15 doi: 10.1016/j.neuropharm.2012.04.007 – ident: S1461145714000662_ref7 doi: 10.1521/suli.2009.39.1.38 – ident: S1461145714000662_ref43 doi: 10.1111/j.1476-5381.2008.00004.x – ident: S1461145714000662_ref12 doi: 10.1001/archpsyc.65.5.521 – ident: S1461145714000662_ref41 doi: 10.1007/BF00964456 – ident: S1461145714000662_ref32 doi: 10.1002/jnr.22078 – ident: S1461145714000662_ref38 doi: 10.1016/j.mehy.2007.03.021 – volume: 25 start-page: 268 year: 2010 ident: S1461145714000662_ref23 publication-title: Eur Psychiatry doi: 10.1016/j.eurpsy.2010.01.009 – ident: S1461145714000662_ref20 doi: 10.1001/jama.2011.1080 – ident: S1461145714000662_ref13 doi: 10.1016/0006-8993(91)90939-S – ident: S1461145714000662_ref18 doi: 10.1111/j.1600-0447.1996.tb09869.x – volume: 277 start-page: 1 year: 1979 ident: S1461145714000662_ref3 publication-title: Acta Psychiatr Scand – ident: S1461145714000662_ref36 doi: 10.1001/archpsyc.1986.01800060071009 – ident: S1461145714000662_ref30 doi: 10.1016/j.brainres.2007.08.007 – ident: S1461145714000662_ref44 doi: 10.1001/archpsyc.63.8.856 – ident: S1461145714000662_ref28 doi: 10.4088/JCP.v69n0308 – ident: S1461145714000662_ref5 doi: 10.1146/annurev.pharmtox.37.1.205 – ident: S1461145714000662_ref27 doi: 10.1016/j.jad.2010.06.003 – ident: S1461145714000662_ref40 doi: 10.1006/geno.2002.6748 – ident: S1461145714000662_ref9 doi: 10.4088/JCP.09m05327blu |
| SSID | ssj0024536 |
| Score | 2.391379 |
| Snippet | Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead to... Abstract Glutamate receptors are promising drug targets for the treatment of urgent suicide ideation and chronic major depressive disorder (MDD) that may lead... |
| SourceID | proquest pubmed crossref oup cambridge |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1569 |
| SubjectTerms | Adolescent Adrenergic Neurons - metabolism Adult Aged Antidepressants Autopsy Depressive Disorder, Major - pathology Female Gene expression Gene Expression - physiology Humans Laser Capture Microdissection Locus Coeruleus - metabolism Locus Coeruleus - pathology Male Mental depression Middle Aged Prefrontal Cortex - metabolism Prefrontal Cortex - pathology Receptors, Glutamate - genetics Receptors, Glutamate - metabolism RNA, Messenger - metabolism |
| Title | Elevated gene expression of glutamate receptors in noradrenergic neurons from the locus coeruleus in major depression |
| URI | https://www.cambridge.org/core/product/identifier/S1461145714000662/type/journal_article https://www.ncbi.nlm.nih.gov/pubmed/24925192 https://www.proquest.com/docview/1561003254 https://www.proquest.com/docview/3169861924 https://www.proquest.com/docview/1561469289 |
| Volume | 17 |
| WOSCitedRecordID | wos000345004900005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVASL databaseName: Oxford Journals Open Access Collection customDbUrl: eissn: 1469-5111 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0024536 issn: 1461-1457 databaseCode: TOX dateStart: 19980701 isFulltext: true titleUrlDefault: https://academic.oup.com/journals/ providerName: Oxford University Press – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1469-5111 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0024536 issn: 1461-1457 databaseCode: 7X7 dateStart: 19980701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1469-5111 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0024536 issn: 1461-1457 databaseCode: BENPR dateStart: 19980701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1469-5111 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0024536 issn: 1461-1457 databaseCode: M2M dateStart: 19980701 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1469-5111 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0024536 issn: 1461-1457 databaseCode: PIMPY dateStart: 19980701 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdYxwMv4xsKYzIS7AE1Iond2HlCgDqBRKsIDak8VfbFQUMl6ZJmYv89Z8dNNw1VSLxEcvwhJz6ff7bvfkfIK1zjkigHHhRChAFX0gS60NrueSDOHZ2KcxT-ImYzOZ-nmT9wa7xZ5UYnOkWdV2DPyN-yKEml2y68W50HNmqUvV31ITT2yL5lKuMDsv9hMsu-btn2xsz7F0VBxMdic69pSaPtS_sOtxiOB_0qu8K1Veqa59sNAOoWopO7__sJ98iBh6D0fScz98ktUz4gx1nHYX05oqdbl6xmRI9ptmW3vnxI2snSXCBAzSmKnqHmt7ekLWlV0B8oxwoxsKGoSM3KRvKhZyUtUc6sx7ipUc9SR6FZNtR6tlDEnxTX07ahUJm6XZrW1filflY17c10y0fk28nk9OOnwMduCCCRYh1oFo8BolRohARjk7NYAjcMIoiFkkKxgoNhLAQjC52rAiQomRimFQdtOQcfk0FZleYpoZBYYCl0EgHnOhSp1nkaK5kzrlA_xUMy6sdt4Wdgs-is18TixjAPSbgZ2gV4HnQbjmO5q8qbvsqqIwHZVfg1ysu_lDvcSMmVXls4G-K_43_N3krQkLzss1Eh2FseVZqq7ZrgSYob6SF50glq3xlLD4mQPX62u_Hn5A7iQt7ZLB6SwbpuzQtyGy7WZ019RPbEXLinPPLzDVPTeIqp7PM0-_4HYN0tiA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VggQX3o-FAkaiPaCN2Dje2DkghKBVq-6u9rBIvQXbcVDRkizJprB_it_I2Hlsq6IVlx64OrYVOfP4Jp75BuA1-rjQTzTzUs4HHpPCeCpVysY8miaOTsUVCo_4ZCJOTqLpFvxua2FsWmVrE52hTnJt_5G_DfwwEi5ceL_44dmuUfZ2tW2hUYvFsVn9xJCtfHf0Cb_vLqUH-7OPh17TVcDToeBLTwV0qLUfcYXOamiSgArNTKB9TbkUXAYp0wajfG1EqhKZaqGlCE2gJNPKsuHhvtfgOsNIyLaKGNPxmttvGDTVTL7nsyFvb1EtRbUdtGMY0DjW9fNcDhd84oU6u0tw17m9gzv_24HdhdsNwCYfao24B1smuw9705qhe9Uns3XBWdkne2S65u5ePYBqf27OEH4nBBXLEPOryRPOSJ6Sr6ilEhG-IegmzML2KSKnGclQi2w9vCnQixBHEJqVxNbtEETXBNFCVRKdm6Kam8qt-C6_5QXpkpCzh_D5So7kEWxneWaeANGhhc1chb5mTA14pFQSUSmSgEm0vrQH_U5O4sa-lHGdm8fjS2LVg0ErSrFuWN5ts5H5piVvuiWLmuJk0-RdlM9_mbfTSuW5t7ZgfYBnx_76eC2xPXjVPUZzZ--wZGbyqt6ChREVUQ8e14rRvYwlv8SAhD7dvPlLuHk4G4_i0dHk-BncQgTM6uzMHdheFpV5Djf02fK0LF447Sbw5aq14w-dWIeT |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Elevated+gene+expression+of+glutamate+receptors+in+noradrenergic+neurons+from+the+locus+coeruleus+in+major+depression&rft.jtitle=The+international+journal+of+neuropsychopharmacology&rft.au=Chandley%2C+Michelle+J&rft.au=Szebeni%2C+Attila&rft.au=Szebeni%2C+Katalin&rft.au=Crawford%2C+Jessica+D&rft.date=2014-10-01&rft.pub=Oxford+University+Press&rft.issn=1461-1457&rft.eissn=1469-5111&rft.volume=17&rft.issue=10&rft.spage=1569&rft.epage=1578&rft_id=info:doi/10.1017%2FS1461145714000662 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1461-1457&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1461-1457&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1461-1457&client=summon |